investigation of anti-mullerian hormone (amh) level and ovarian response in infertile women with endometriosis in ivf cycles

Background: endometriosis, can cause ovarian conflict and reduced ovarian reserve that could lead to lower response to assisted reproductive techniques objective: current study was conducted to determine the association between level of anti-mullerian hormone (amh) and the infertility treatment outcomes in infertile females with endometriosis versus the non-endometriosis infertile subject. materials and methods: in this case-control study, 64 infertile females who referred to shariati hospital from april 2015 to november 2017 were enrolled. they were divided in two groups of 32 patients (endometriosis and non-endometriosis women). the anti-mullerian hormone level among all subjects was determined, treatment outcomes were evaluated and association between these factors was assessed. results: it was seen that the anti-mullerian hormone (p=0.06), the number of retrieved oocytes (p=0.7) and embryos (p=0.7), implantation rate (p=0.6) and clinical pregnancy rate (p=0.9) were similar between two groups. in patients with stage 3 or 4 endometriosis who had lower serum amh level significantly (p=0.001) less oocytes were retrieved (p=0.001) and less transferrable embryos (p=0.03) were achieved. however, implantation and pregnancy rates did not differ (p=0.7) (p=0.6). conclusion: totally, according to the obtained results, it may be concluded that ovarian reserve has more significant role in predicting infertility treatment outcome rather than receptive endometrium